AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...

AI and machine learning can transform fragmented and unstructured healthcare data. But how do you refine it into useful, ...

Scientists at Mass General Brigham in Boston have developed an AI tool called FaceAge, an algorithm designed to tell patients ...

The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

Johns Hopkins University School of Medicine received a $10 million donation for an endowed AI center to further research and innovation in clinical and non-clinical spaces. There is rapid evolution of ...

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

The U.S. Food and Drug Administration (FDA) has unveiled a historic initiative to implement artificial intelligence (AI) ...